000			01582 a2200505 4500
005			20250515170823.0
264		0	_c20090630
008			200906s 0 0 eng d
022			_a1526-632X
024	7		_a10.1212/WNL.0b013e3181a41211 _2doi
040			_aNLM _beng _cNLM
100	1		_aAlshekhlee, A
245	0	0	_aIncidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. _h[electronic resource]
260			_bNeurology _cMay 2009
300			_a1548-54 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAge Distribution
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCohort Studies
650	0	4	_aComorbidity
650	0	4	_aFemale
650	0	4	_aHospitals _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aImmunoglobulins, Intravenous _xtherapeutic use
650	0	4	_aIncidence
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMortality
650	0	4	_aMuscle, Skeletal _xmetabolism
650	0	4	_aMyasthenia Gravis _xdrug therapy
650	0	4	_aRacial Groups
650	0	4	_aRespiratory Insufficiency _xmortality
650	0	4	_aRespiratory Muscles _xmetabolism
650	0	4	_aSex Distribution
650	0	4	_aUnited States _xepidemiology
650	0	4	_aYoung Adult
700	1		_aMiles, J D
700	1		_aKatirji, B
700	1		_aPreston, D C
700	1		_aKaminski, H J
773	0		_tNeurology _gvol. 72 _gno. 18 _gp. 1548-54
856	4	0	_uhttps://doi.org/10.1212/WNL.0b013e3181a41211 _zAvailable from publisher's website
999			_c18843668 _d18843668